Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Recruiting · NCT05874414 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, bile duct disorder, bile duct neoplasm, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-07-13 | NCT05874414 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genfit | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee | United States | 27 |
| Hospital of the University of Pennsylvania | Philadelphia | United States | 142 |
| LACN Aneheim Flagship Office | Los Angeles | United States | 1 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Orlando Health | Orlando | United States | 64 |
| Pan American Center for Oncology Trials, LLC | Rio Piedras | Puerto Rico | 1 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| University of Chicago Medical Center | Chicago | United States | 152 |
| University of Texas, MD Anderson Cancer Center | Houston | United States | 12 |
| University of Virginia Comprehensive Cancer Center | Charlottesville | United States | 7 |
| Usc Norris Comprehensive Cancer Center | Los Angeles | United States | 67 |